Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
possible neurological issues
possible respiratory issues |
| gptkbp:caused_by |
gptkb:H1_N1_influenza_virus
|
| gptkbp:community_impact |
increased anxiety
changes in social behavior |
| gptkbp:defense |
declared a pandemic
|
| gptkbp:economic_impact |
increased healthcare costs
disruption of businesses |
| gptkbp:end_of_life |
0.02% to 0.05%
151,700 to 575,400 |
| gptkbp:ends_at |
August 2010
|
| gptkbp:genetic_diversity |
reassortant virus
|
| gptkbp:government_type |
gptkb:quarantine_measures
travel restrictions |
| gptkbp:healthcare |
public awareness campaigns
surveillance vaccination campaigns |
| https://www.w3.org/2000/01/rdf-schema#label |
2009 H1 N1 pandemic
|
| gptkbp:involved_countries |
worldwide
|
| gptkbp:is_affected_by |
all age groups
|
| gptkbp:is_vulnerable_to |
gptkb:2009_H1_N1_vaccine
October 2009 1.4 billion |
| gptkbp:legacy |
improved pandemic preparedness
enhanced global surveillance systems increased vaccine research funding |
| gptkbp:location |
gptkb:Mexico
gptkb:United_States |
| gptkbp:media_coverage |
extensive
|
| gptkbp:origin |
swine
|
| gptkbp:related_to |
seasonal flu
|
| gptkbp:research_focus |
public health preparedness
vaccine effectiveness viral transmission |
| gptkbp:risk_factor |
pregnant women
young children people with chronic health conditions |
| gptkbp:sensor |
April 2009
|
| gptkbp:social_responsibility |
A virus
|
| gptkbp:successor |
Phase 6
|
| gptkbp:symptoms |
fatigue
headache cough fever sore throat chills body aches runny or stuffy nose |
| gptkbp:transmission |
airborne droplets
person-to-person |
| gptkbp:treatment |
supportive care
antiviral medications |
| gptkbp:bfsParent |
gptkb:Orthomyxoviridae
|
| gptkbp:bfsLayer |
5
|